title: Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients.
abstract: The utility of galactomannan antigen for diagnosing invasive aspergillosis was evaluated in 154 liver transplant recipients. Sample agreement was 98.5%, and patient specificity was 87%. Galactomannan positivity correlated with mortality, even when controlled for the number of tests performed. Whether galactomannan positivity identifies a subgroup at risk for poor outcome warrants further evaluation.
authors.affiliation: Thomas E Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15240, USA.
authors.forename: Eun Jeong
authors.initials: EJ
authors.lastname: Kwak
authors.forename: Shahid
authors.initials: S
authors.lastname: Husain
authors.forename: Asia
authors.initials: A
authors.lastname: Obman
authors.forename: Lisa
authors.initials: L
authors.lastname: Meinke
authors.forename: Janet
authors.initials: J
authors.lastname: Stout
authors.forename: Shimon
authors.initials: S
authors.lastname: Kusne
authors.forename: Marilyn M
authors.initials: MM
authors.lastname: Wagener
authors.forename: Nina
authors.initials: N
authors.lastname: Singh
mesh_terms: D000328:Adult; D000368:Aged; D001228:Aspergillosis / Q000175:diagnosis*; D005260:Female; D005690:Galactose / Q000031:analogs & derivatives; D006801:Humans; D007124:Immunoenzyme Techniques; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D008351:Mannans / Q000032:analysis*; D008875:Middle Aged
chemical_list: D008351:Mannans; C012990:galactomannan; D005690:Galactose